Competition critic
Executive Summary
From the Republican side, Oklahoma Rep. Coburn continued his recent attacks on drug pricing and competition. Restricted to one minute by the majority, Coburn charged that the debate was on the wrong subject. "What we are doing is the wrong thing," Coburn said. "The politics of Washington is claiming to fix a problem that is very real, but it is fixing the wrong problem. The problem is there is no competition within the pharmaceutical industry"